美股A股
StockGist
Back
6-K2026-03-31· deepseek-chat

IH · iHuman Inc.

0001104659-26-037392

SEC filing

Summary

iHuman Inc. reported lower unaudited financial results for Q4 and fiscal year 2025, with revenues declining to RMB190.7 million and RMB807.0 million respectively, primarily due to China's declining newborn population and conservative consumer spending.

Key takeaways

Full analysis

iHuman Inc. reported lower unaudited financial results for both the fourth quarter and full fiscal year 2025, with revenues declining to RMB190.7 million and RMB807.0 million respectively. The company attributed these declines primarily to China's declining newborn population and more conservative consumer spending, which also drove a decrease in average total MAUs to 23.57 million in Q4 2025 from 25.78 million in the same period last year. Despite the revenue decline, the company maintained operational efficiency with total operating expenses decreasing 16.3% in Q4 2025 to RMB118.5 million, driven by savings in payroll-related expenses across research and development, sales and marketing, and general and administrative functions. Management highlighted strategic initiatives including the launch of FreeTalk, an AI-native oral English application designed to expand beyond childhood education into broader user segments, and the introduction of new interactive modules within iHuman Chinese and the iHuman AI Bilingual Early Learning Tablet. The company's international expansion showed progress with Aha World experiencing approximately 30% growth in daily active users on the U.S. Apple App Store during the holiday period. Reflecting confidence in the business, the board approved a special cash dividend of US$0.10 per ADS totaling approximately US$5.1 million, marking the third consecutive year of special dividend declarations. The company ended the year with RMB1,151.1 million in cash, cash equivalents and short-term investments, providing financial flexibility for continued product innovation and strategic initiatives.